Alternate day fasting aggravates atherosclerosis through the suppression of hepatic ATF3 in Apoe^−/− mice

Abstract

Atherosclerosis is the major contributor to cardiovascular mortality worldwide. Alternate day fasting (ADF) has gained growing attention due to its metabolic benefits. However, the effects of ADF on atherosclerotic plaque formation remain inconsistent and controversial in atherosclerotic animal models. The present study was designed to investigate the effects of ADF on atherosclerosis in apolipoprotein E-deficient (Apoe^−/−) mice. Eleven-week-old male Apoe^−/− mice fed with Western diet (WD) were randomly grouped into ad libitum (AL) group and ADF group, and ADF aggravated both the early and advanced atherosclerotic lesion formation, which might be due to the disturbed cholesterol profiles caused by ADF intervention. ADF significantly altered cholesterol metabolism pathways and down-regulated integrated stress response (ISR) in the liver. The hepatic expression of activating transcription factor 3 (ATF3) was suppressed in mice treated with ADF and hepatocyte-specific overexpression of Aft3 attenuated the effects of ADF on atherosclerotic plaque formation in Apoe^−/− mice. Moreover, the expression of ATF3 could be regulated by Krüppel-like factor 6 (KLF6) and both the expressions of ATF3 and KLF6 were regulated by hepatic cellular ISR pathway. In conclusion, ADF aggravates atherosclerosis progression in Apoe^−/− mice fed on WD. ADF inhibits the hepatic ISR signaling pathway and decreases the expression of KLF6, subsequently inhibiting ATF3 expression. The suppressed ATF3 expression in the liver mediates the deteriorated effects of ADF on atherosclerosis in Apoe^−/− mice. The findings suggest the potentially harmful effects when ADF intervention is applied to the population at high risk of atherosclerosis.

Keywords

alternate day fasting / atherosclerosis / cholesterol / integrated stress response / activating transcription factor 3

References

[1] Ma LY , Chen WW , Gao RL et al. China cardiovascular diseases report 2018: an updated summary. J Geriatr Cardiol 2020; 17: 1- 8.

[2] Tabas I , Williams KJ , Boren J . Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007; 116: 1832- 44.

[3] Ley K , Miller YI , Hedrick CC . Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol 2011; 31: 1506- 16.

[4] Basatemur GL , Jorgensen HF , Clarke MCH et al. Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol 2019; 16: 727- 44.

[5] Aboonabi A , Meyer RR , Singh I . The association between metabolic syndrome components and the development of atherosclerosis. J Hum Hypertens 2019; 33: 844- 55.

[6] Rinella ME . Nonalcoholic fatty liver disease: a systematic review. JAMA 2015; 313: 2263- 73.

[7] de Cabo R , Mattson MP . Effects of intermittent fasting on health, aging, and disease. N Engl J Med 2019; 381: 2541- 51.

[8] Zhang H , Zhang W , Yun D et al. Alternate-day fasting alleviates diabetes-induced glycolipid metabolism disorders: roles of FGF21 and bile acids. J Nutr Biochem 2020; 83: 108403.

[9] Kim KH , Kim YH , Son JE et al. Intermittent fasting promotes adipose thermogenesis and metabolic homeostasis via VEGF-mediated alternative activation of macrophage. Cell Res 2017; 27: 1309- 26.

[10] Li G , Xie C , Lu S et al. Intermittent fasting promotes white adipose browning and decreases obesity by shaping the gut microbiota. Cell Metab 2017; 26: 801.

[11] Hatchwell L , Harney DJ , Cielesh M et al. Multi-omics analysis of the intermittent fasting response in mice identifies an unexpected role for HNF4α. Cell Rep 2020; 30: 3566- 82.e4.

[12] Liu X , Zhang Y , Ma C et al. Alternate-day fasting alleviates high fat diet induced non-alcoholic fatty liver disease through controlling PPARα/Fgf21 signaling. Mol Biol Rep 2022; 49: 3113- 22.

[13] Marinho TS , Ornellas F , Barbosa-da-Silva S et al. Beneficial effects of intermittent fasting on steatosis and inflammation of the liver in mice fed a high-fat or a high-fructose diet. Nutrition 2019; 65: 103- 12.

[14] Patikorn C , Roubal K , Veettil SK et al. Intermittent fasting and obesity-related health outcomes: an umbrella review of meta-analyses of randomized clinical trials. JAMA Netw Open 2021; 4: e2139558.

[15] Hoddy KK , Kroeger CM , Trepanowski JF et al. Meal timing during alternate day fasting: impact on body weight and cardiovascular disease risk in obese adults. Obesity (Silver Spring) 2014; 22: 2524- 31.

[16] Varady KA , Bhutani S , Church EC et al. Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr 2009; 90: 1138- 43.

[17] Stekovic S , Hofer SJ , Tripolt N et al. Alternate day fasting improves physiological and molecular markers of aging in healthy, nonobese humans. Cell Metab 2019; 30: 462- 76.e6.

[18] Johnson JB , Summer W , Cutler RG et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med 2007; 42: 665- 74.

[19] Yang W , Cao M , Mao X et al. Alternate-day fasting protects the livers of mice against high-fat diet-induced inflammation associated with the suppression of Toll-like receptor 4/nuclear factor κB signaling. Nutr Res 2016; 36: 586- 93.

[20] Dai S , Wei J , Zhang H et al. Intermittent fasting reduces neuroinflammation in intracerebral hemorrhage through the Sirt3/Nrf2/HO-1 pathway. J Neuroinflammation 2022; 19: 122.

[21] Dorighello GG , Rovani JC , Luhman CJ et al. Food restriction by intermittent fasting induces diabetes and obesity and aggravates spontaneous atherosclerosis development in hypercholesterolaemic mice. Br J Nutr 2014; 111: 979- 86.

[22] Inoue KI , Toyoda S , Jojima T et al. Time-restricted feeding prevents high-fat and high-cholesterol diet-induced obesity but fails to ameliorate atherosclerosis in apolipoprotein E-knockout mice. Exp Anim 2021; 70: 194- 202.

[23] Chen Y , Su J , Yan Y et al. Intermittent fasting inhibits high-fat diet-induced atherosclerosis by ameliorating hypercholesterolemia and reducing monocyte chemoattraction. Front Pharmacol 2021; 12: 719750.

[24] Moore KJ , Sheedy FJ , Fisher EA . Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 2013; 13: 709- 21.

[25] Pakos-Zebrucka K , Koryga I , Mnich K et al. The integrated stress response. EMBO Rep 2016; 17: 1374- 95.

[26] Ron D . Translational control in the endoplasmic reticulum stress response. J Clin Invest 2002; 110: 1383- 8.

[27] Xu Y , Li Y , Jadhav K et al. Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism. Nat Metab 2021; 3: 59- 74.

[28] Zhao J , Li X , Guo M et al. The common stress responsive transcription factor ATF3 binds genomic sites enriched with p300 and H3K27ac for transcriptional regulation. BMC Genomics 2016; 17: 335.

[29] Zhang D , Lin J , Chao Y et al. Regulation of the adaptation to ER stress by KLF4 facilitates melanoma cell metastasis via upregulating NUCB2 expression. J Exp Clin Cancer Res 2018; 37: 176.

[30] Mungrue IN , Pagnon J , Kohannim O et al. CHAC1/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4-ATF3-CHOP cascade. J Immunol 2009; 182: 466- 76.

[31] Huang X , Li X , Guo B . KLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3. J Biol Chem 2008; 283: 29795- 801.

[32] Chou A , Krukowski K , Jopson T et al. Inhibition of the integrated stress response reverses cognitive deficits after traumatic brain injury. Proc Natl Acad Sci U S A 2017; 114: E6420- 6.

[33] Mahley RW . Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622- 30.

[34] Pendse AA , Arbones-Mainar JM , Johnson LA et al. Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. J Lipid Res 2009; 50 (Suppl): S178- 82.

[35] Meir KS , Leitersdorf E . Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 2004; 24: 1006- 14.

[36] Bennet AM , Di Angelantonio E , Ye Z et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007; 298: 1300- 11.

[37] Yousuf FA , Iqbal MP . Review: apolipoprotein E (Apo E) gene polymorphism and coronary heart disease in Asian populations. Pak J Pharm Sci 2015; 28: 1439- 44.

[38] Lehtimaki T , Frankberg-Lakkala H , Solakivi T et al. The effect of short-term fasting, apolipoprotein E gene polymorphism, and sex on plasma lipids. Am J Clin Nutr 1997; 66: 599- 605.

[39] Moreno JA , Perez-Jimenez F , Marin C et al. The effect of dietary fat on LDL size is influenced by apolipoprotein E genotype in healthy subjects. J Nutr 2004; 134: 2517- 22.

[40] Ku HC , Cheng CF . Master regulator activating transcription factor 3 (ATF3) in metabolic homeostasis and cancer. Front Endocrinol (Lausanne) 2020; 11: 556.

[41] Allen-Jennings AE , Hartman MG , Kociba GJ et al. The roles of ATF3 in liver dysfunction and the regulation of phosphoenolpyruvate carboxykinase gene expression. J Biol Chem 2002; 277: 20020- 5.

[42] Cheng CF , Ku HC , Cheng JJ et al. Adipocyte browning and resistance to obesity in mice is induced by expression of ATF3. Commun Biol 2019; 2: 389.

[43] Xu Y , Hu S , Jadhav K et al. Hepatocytic activating transcription factor 3 protects against steatohepatitis via hepatocyte nuclear factor 4α. Diabetes 2021; 70: 2506- 17.

[44] Chambers KF , Day PE , Aboufarrag HT et al. Polyphenol effects on cholesterol metabolism via bile acid biosynthesis, CYP7A1: a review. Nutrients 2019; 11: 2588.

[45] Wang JK , Li Y , Zhao XL et al. Ablation of plasma prekallikrein decreases low-density lipoprotein cholesterol by stabilizing low-density lipoprotein receptor and protects against atherosclerosis. Circulation 2022; 145: 675- 87.

[46] Santos-Ribeiro D , Godinas L , Pilette C et al. The integrated stress response system in cardiovascular disease. Drug Discov Today 2018; 23: 920- 9.

[47] Xu X , Krumm C , So JS et al. Preemptive activation of the integrated stress response protects mice from diet-induced obesity and insulin resistance by fibroblast growth factor 21 induction. Hepatology 2018; 68: 2167- 81.

[48] Colgan SM , Tang D , Werstuck GH et al. Endoplasmic reticulum stress causes the activation of sterol regulatory element binding protein-2. Int J Biochem Cell Biol 2007; 39: 1843- 51.

[49] Werstuck GH , Lentz SR , Dayal S et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001; 107: 1263- 73.

[50] Harding HP , Zhang Y , Khersonsky S et al. Bioactive small molecules reveal antagonism between the integrated stress response and sterol-regulated gene expression. Cell Metab 2005; 2: 361- 71.

[51] Urtasun R , Cubero FJ , Nieto N . Oxidative stress modulates KLF6_Full and its splice variants. Alcohol Clin Exp Res 2012; 36: 1851- 62.

[52] La Sala L , Pujadas G , De Nigris V et al. Oscillating glucose and constant high glucose induce endoglin expression in endothelial cells: the role of oxidative stress. Acta Diabetol 2015; 52: 505- 12.

[53] Sun J , Cai J , Chen J et al. Krüppel-like factor 6 silencing prevents oxidative stress and neurological dysfunction following intracerebral hemorrhage via Sirtuin 5/Nrf2/HO-1 Axis. Front Aging Neurosci 2021; 13: 646729.

[54] Song F , Li S , Dai X et al. Activation of KLF6 by titanate nanofibers and regulatory roles of KLF6 on ATF3 in the endothelial monolayer and mouse aortas. Mol Omics 2023; 19: 150- 61.

[55] Xiong Q , Zhang Z , Yang Y et al. Krüppel-like factor 6 suppresses the progression of pancreatic cancer by upregulating activating transcription factor 3. J Clin Med 2022; 12: 200.

[56] Kleiner DE , Brunt EM , Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313- 21.

[57] Young-Baird SK , Lourenco MB , Elder MK et al. Suppression of MEHMO syndrome mutation in eIF2 by Small Molecule ISRIB. Mol Cell 2020; 77: 875- 86.e7.

RIGHTS & PERMISSIONS

2024 The Author(s) 2024. Published by Oxford University Press on behalf of Higher Education Press.